Quantcast

Latest Tumor necrosis factor-alpha Stories

2011-01-05 07:00:00

MALVERN, Pa., Jan. 5, 2011 /PRNewswire/ -- TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced that is has closed the $23 million second tranche of a Series C financing completed in October 2010.

2011-01-04 14:12:00

Patients with early rheumatoid arthritis (RA) who are current smokers were less likely to achieve good response to methotrexate (MTX) and tumor necrosis factor (TNF) inhibitors than those who never smoked.

2010-12-23 17:52:44

A study was carried out to examine the extent to which quercetin and trans-resveratrol (RSV) prevented inflammation or insulin resistance in primary cultures of human adipocytes treated with tumor necrosis factor-a (TNF-a)—an inflammatory cytokine elevated in the plasma and adipose tissue of obese, diabetic individuals.

2010-11-08 07:15:00

LOS ANGELES, Nov. 8, 2010 /PRNewswire-USNewswire/ -- Three new studies provide converging evidence pointing to a new therapeutic target in Alzheimer's Disease(AD).

2010-11-08 08:13:22

Remember that groggy, barely conscious feeling you had following a surgical procedure?

2010-11-04 01:11:55

A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA).


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related